A specialty of the MEL^® 90 from ZEISS is the Triple-A Advanced Ablation Algorithm. It is a single ablation profile for a wide range of sphero-cylindrical (SCA) corrections that simplifies treatment planning. Triple-A offers a high degree of precision, reproducibility and predictability, as well as advantages such as the controlled induction of spherical aberrations and tissue-saving ablation.

Its preinstalled functions also offer surgeons optimal support for achieving excellent treatment results and gentle treatments of standard, higher and lower level of ametropia as well as astigmatism.

Indications for use

The MEL 90 is indicated for use in primary Laser-Assisted in situ Keratomileusis (LASIK) treatments for the reduction or elimination of:

• Myopia less in magnitude than -10.00 D sphere (in minus-cylinder notation), with and without cylinder up to -4.00 D, when MRSE is less in magnitude than -10.00 D;
• Hyperopia up to +4.00 D sphere (in plus-cylinder notation), with and without cylinder up to +3.00 D, when MRSE is up to +5.00 D;
• Mixed astigmatism with cylinder from >1.00 D up to 4.00 D and

in patients who are 18 years of age or older with documentation of stable manifest refraction over the past year as demonstrated by a change in MRSE within +/- 0.50 D.

As a true team player, the ZEISS MEL 90 excimer laser greatly simplifies the interactions between the surgeon, the assisting staff and the system technology. The excimer laser can be configured to precisely match the surgeon and OR team`s needs. The ZEISS MEL 90 is a highly reliable system requiring very little service maintenance. The system's simple, intuitive graphic user interface supports fast treatment procedures. The ZEISS MEL 90 patient bed LS Comfort 80 combi enables the combination with ZEISS VISUMAX^® 800 femtosecond laser.